---
title: "Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (300313.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300313.SZ.md"
symbol: "300313.SZ"
name: "Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd."
industry: "Biotechnology"
datetime: "2026-05-20T19:29:29.660Z"
locales:
  - [en](https://longbridge.com/en/quote/300313.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300313.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300313.SZ.md)
---

# Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (300313.SZ)

## Company Overview

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. engages in the provision of cattle breeding products and services in China. The company offers frozen semen and embryos of self-produced bulls and products, including breeds of Holstein, Brown, Simmental, Charolais, Angus, and Limousin; fattening cattle; and sheep frozen semen and embryo products. It is also involved in the promotion and sales of young breeding cows and pregnant cows; cattle and sheep breeding planning, reproduction trusteeship, hoof care, milk parlor testing, feeding management consulting, fattening technology, and other services; live cattle and sheep; beef and mutton products; ranch, agricultural land management and leasing services; and sale of milk and other by-products.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | CN Market |
| Website | [www.xjtssw.com](https://www.xjtssw.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: C (0.46)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Ranking | 65 / 81 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 103.31% |  |
| Net Profit YoY | 71.64% |  |
| P/B Ratio | 60.70 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2233911059.03 |  |
| Revenue | 294733453.20 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -129.03% | E |
| Profit Margin | -6.14% | D |
| Gross Margin | 9.85% | E |
| Revenue YoY | 103.31% | A |
| Net Profit YoY | 71.64% | A |
| Total Assets YoY | 23.09% | A |
| Net Assets YoY | 5577.48% | A |
| Cash Flow Margin | 32.78% | D |
| OCF YoY | 103.31% | A |
| Turnover | 1.10 | A |
| Gearing Ratio | 82.61% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "103.31%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "71.64%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "60.70",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "2233911059.03",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "294733453.20",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-129.03%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-6.14%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "9.85%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "103.31%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "71.64%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "23.09%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "5577.48%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "32.78%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "103.31%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "1.10",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "82.61%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -124.24 | 73/81 | - | - | - |
| PB | 61.09 | 80/81 | 66.44 | 57.86 | 52.77 |
| PS (TTM) | 7.63 | 35/81 | 22.70 | 20.12 | 15.51 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Sunshine Guojian Pharmaceutical (688336.SH) | A | A | B | A | B | A |
| 02 | AMOYTOP (688278.SH) | A | A | A | A | B | A |
| 03 | BeOne Medicines (688235.SH) | B | A | B | C | A | B |
| 04 | RemeGen (688331.SH) | A | A | C | C | B | B |
| 05 | InnoCare Pharma (688428.SH) | B | A | D | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300313.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300313.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300313.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300313.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**